Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bayer Talks Up Pharma Prospects Post-Xarelto

Mar 06 2024

• By Kevin Grogan

Anderson — CEO Bill Anderson at Bayer's news conference in London on 5 March, flanked by chief talent officer Heike Prinz and CFO Wolfgang Nickl • Source: Bayer

Related Content

Bayer Hot On The Trail Of Astellas As Menopause Drug Flies In Phase III

Jan 08 2024

Bayer Expands Kerendia Program In Competitive Heart Failure Space

Sep 01 2023

Related Companies

Bayer AG

Johnson & Johnson

Additional Topics

Sales & Earnings Business Strategies Women's Health Commercial Advanced Therapies BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.